BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05494762-completion@plaintrial.com
DTSTAMP:20261027T131840Z
DTSTART;VALUE=DATE:20250224
SUMMARY:Safety\, Pharmacokinetics\, and Antitumor Activity of BGB-B167 Alon
 e and in Combination With Tislelizumab (BGB-A317) in Participants With Adv
 anced Solid Tumors — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05494762
URL:https://plaintrial.com/trial/NCT05494762
END:VEVENT
END:VCALENDAR